Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Toxicol (Phila) ; 57(10): 847-854, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30786220

RESUMEN

Context: Kratom, or Mitragyna speciosa, is a plant indigenous to Southeast Asia that has gained national attention in the United States for its increased use in the self-management of opioid withdrawal and pain, as well as for concerns about its safety. Methods: This study analyzes exposures to kratom reported to poison control centers (PCCs) in the United States during 2011-2017 from the National Poison Data System (NPDS). Discussion: From 2011 through 2017, 1807 kratom exposures were reported to United States PCCs. Almost two-thirds (65.0%) of these exposures occurred during 2016-2017. Most exposures occurred among adults ≥20 years (88.9%), males (70.8%), at a residence (86.1%), and were intentional (74.3%). Among first-ranked kratom exposures, 31.8% resulted in admission to a health care facility (HCF) and 51.9% in a serious medical outcome. Multiple-substance exposures were associated with greater odds of admission to a HCF (OR: 2.80; 95% CI: 2.21-3.55) and a serious medical outcome (OR: 2.25; 95% CI: 1.77-2.85) compared with single-substance exposures. There were 11 deaths associated with kratom exposure, including two that occurred after exposure to kratom only. Among kratom-only exposures, 86.1% resulted in one or more clinical effects. The most common clinical effects were agitation/irritability (22.9%) and tachycardia (21.4%). There were seven neonatal exposures, including five experiencing withdrawal. Conclusions: Kratom is associated with a variety of serious medical outcomes, especially when used with other substances. More research is needed to define the human response to kratom. Increased regulation of kratom products would help guarantee product quality and safety. Individuals who choose to use kratom should be educated about its potential risks, including the dangers of using it in combination with other substances.


Asunto(s)
Analgésicos/envenenamiento , Hospitalización/estadística & datos numéricos , Mitragyna/envenenamiento , Dolor/tratamiento farmacológico , Extractos Vegetales/envenenamiento , Centros de Control de Intoxicaciones/estadística & datos numéricos , Síndrome de Abstinencia a Sustancias/tratamiento farmacológico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Intoxicación/epidemiología , Estados Unidos/epidemiología , Adulto Joven
3.
J Med Toxicol ; 13(3): 227-237, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28741126

RESUMEN

INTRODUCTION: The objective of this study was to investigate the epidemiology of dietary supplement exposures in the USA. METHODS: A retrospective analysis was conducted of out-of-hospital dietary supplement exposures reported to the National Poison Data System from 2000 through 2012. RESULTS: There were 274,998 dietary supplement exposures from 2000 through 2012. The annual rate of dietary supplement exposures per 100,000 population increased by 46.1% during 2000-2002, decreased 8.8% during 2002-2005, and then increased again by 49.3% from 2005 to 2012. These trends were influenced by the decrease in ma huang exposures starting in 2002. Miscellaneous dietary supplements accounted for 43.9% of all exposures, followed by botanicals (31.9%), hormonal products (15.1%), and other supplements (5.1%). The majority of dietary supplement exposures (70.0%) occurred among children younger than 6 years old and were acute (94.0%) and unintentional (82.9%). Serious medical outcomes accounted for 4.5% of exposures and most (95.0%) occurred among individuals 6 years and older. Ma huang products, yohimbe, and energy products were the categories associated with the greatest toxicity. CONCLUSIONS: There was an overall increase in the rate of dietary supplement exposures from 2000 through 2012. Although the majority of these exposures did not require treatment at a health care facility or result in serious medical outcomes, exposures to yohimbe and energy products were associated with considerable toxicity. Our results demonstrate the success of the FDA ban on ma huang products and the need for FDA regulation of yohimbe and energy products in the USA.


Asunto(s)
Suplementos Dietéticos/envenenamiento , Bebidas Energéticas/envenenamiento , Preparaciones de Plantas/envenenamiento , Centros de Control de Intoxicaciones/tendencias , Yohimbina/envenenamiento , Adolescente , Adulto , Niño , Preescolar , Bases de Datos Factuales , Suplementos Dietéticos/provisión & distribución , Bebidas Energéticas/provisión & distribución , Ephedra sinica , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Preparaciones de Plantas/provisión & distribución , Intoxicación/diagnóstico , Intoxicación/epidemiología , Intoxicación/terapia , Estudios Retrospectivos , Medición de Riesgo , Retirada de Medicamento por Seguridad , Factores de Tiempo , Estados Unidos/epidemiología , United States Food and Drug Administration , Yohimbina/provisión & distribución , Adulto Joven
5.
J Sci Med Sport ; 10(4): 219-26, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16914371

RESUMEN

Although an estimated 6.5 million United States (US) children aged 6-17 practiced a martial art in 2004, there have been no nationally representative studies comparing pediatric injuries among the three most popular disciplines, karate, taekwondo, and judo. Describe pediatric martial arts injuries presenting to a representative sample of US Emergency Departments (EDs) from 1990 to 2003. We reviewed all martial arts injuries captured by the US Consumer Product Safety Commission's (CPSC), National Electronic Injury Surveillance System (NEISS). An estimated 128,400 children

Asunto(s)
Servicio de Urgencia en Hospital/estadística & datos numéricos , Artes Marciales/lesiones , Adolescente , Traumatismos en Atletas/epidemiología , Niño , Femenino , Humanos , Masculino , Estados Unidos/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA